NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

Just my take. When Flaskworks is approved sometime in the future (don’t know when), you won’t need as many highly educated people to oversee DCVax-l manufacturing. Those highly educated people are still really valuable for Advent to retain, and their pathway to non-NWBO-dilutive locations, is important. JMHO.

I know this didn’t completely answer your question, but I think retention is a big consideration.